Cargando…
Levothyroxine Dose Adjustment to Optimise Therapy Throughout a Patient’s Lifetime
Levothyroxine is the standard therapy for patients with hypothyroidism, a condition that affects up to 5% of people worldwide. While levothyroxine therapy has substantially improved the lives of millions of hypothyroid patients since its introduction in 1949, the complexity of maintaining biochemica...
Autores principales: | Duntas, Leonidas H., Jonklaas, Jacqueline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822824/ https://www.ncbi.nlm.nih.gov/pubmed/31485977 http://dx.doi.org/10.1007/s12325-019-01078-2 |
Ejemplares similares
-
COVID-19 and Thyroid Diseases: A Bidirectional Impact
por: Duntas, Leonidas H, et al.
Publicado: (2021) -
Seven Decades of Levothyroxine: A Comprehensive Profile
por: Duntas, Leonidas H.
Publicado: (2019) -
Factors influencing the levothyroxine dose in the hormone replacement therapy of primary hypothyroidism in adults
por: Caron, Philippe, et al.
Publicado: (2021) -
The ages and TSH values of patients being prescribed levothyroxine
por: Jonklaas, Jacqueline, et al.
Publicado: (2020) -
Levothyroxine prescriptions trends may indicate a downtrend in
prescribing
por: Jonklaas, Jacqueline, et al.
Publicado: (2020)